إعلان
إعلان

OSCR

OSCR logo

Oscar Health, Inc.

16.50
USD
برعاية
-0.02
-0.15%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

16.52

+0.03
+0.18%

تقارير أرباح OSCR

النسبة الإيجابية المفاجئة

OSCR تفوق 10 من 19 آخر التقديرات.

53%

التقرير التالي

بيانات التقرير القادم
٠٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$3.19B
/
-$0.90
التغير الضمني من Q3 25 (Revenue/ EPS)
+6.71%
/
+69.81%
التغير الضمني من Q4 24 (Revenue/ EPS)
+33.19%
/
+45.16%

Oscar Health, Inc. earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, OSCR reported earnings of -0.53 USD per share (EPS) for Q3 25, beating the estimate of -0.56 USD, resulting in a 6.64% surprise. Revenue reached 2.99 مليار, compared to an expected 3.14 مليار, with a -5.02% difference. The market reacted with a -2.76% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 المحللين forecast an EPS of -0.90 USD, with revenue projected to reach 3.19 مليار USD, implying an زيادة of 69.81% EPS, and زيادة of 6.71% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Oscar Health, Inc. reported EPS of -$0.53, beating estimates by 6.64%, and revenue of $2.99B, -5.02% below expectations.
The stock price moved down -2.76%, changed from $17.03 before the earnings release to $16.56 the day after.
The next earning report is scheduled for ٠٥ فبراير ٢٠٢٦.
Based on 13 المحللين, Oscar Health, Inc. is expected to report EPS of -$0.90 and revenue of $3.19B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان